Real-world experience of postoperative adjuvant chemoimmunotherapy in patients with pancreatobiliary subtype ampullary adenocarcinoma
Compared with surgery alone or adjuvant chemotherapy, patients with pancreatobiliary subtype AAC who received adjuvant chemoimmunotherapy showed better OS, and the drug-related toxicity was acceptable.
Authors
- Yan‐Fang Ye (ORCID: https://orcid.org/0000-0002-5800-8377)
- Xianhuan Yu
- Jiahao Xue
- Xiang-de Shi
- Chao Liu
- Kaixun Huang (ORCID: https://orcid.org/0000-0001-7498-4397)
- Qibin Tang
- Xinjun Lu (ORCID: https://orcid.org/0000-0002-7643-0854)
Institutions
- Sun Yat-sen University (CN)
- Sun Yat-sen Memorial Hospital (CN)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-05-23
- DOI
- https://doi.org/10.1093/oncolo/oyaf104
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun Yat-sen University
- Guangzhou Municipal Science and Technology Project